The incidence of dysrhythmias after administration of the antipsychotic olanzapine
European Pharmaceutical Journal · 2016
DOI: 10.1515/afpuc-2016-0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Pharmaceutical Journal, 2016. Verfasst von P. Gulač und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We evaluated the effect of the antipsychotic olanzapine on electrical activity of rat hearts under conditions of ischemic- reperfusion injury. We focused on the prolongation of the corrected QT interval as a risk factor for the incidence of different types of dysrhythmias. Pretreatment with olanzapine showed prolongation of the corrected QT interval as well as increased incidence of dysrhythmias in following order: ventricular premature beats > bigeminies > trigeminies > salvos. We also observed an increase in the frequency of episodes of ventricular tachycardia of about 64% and the average duration of ventricular tachycardia was more than doubled under the conditions of the ischemic-reperfusion injury.
Zitieren
APA
Gulač, P., Vicen, M., Hričáková, S., & Stankovičová, T. (2016). The incidence of dysrhythmias after administration of the antipsychotic olanzapine. European Pharmaceutical Journal. https://doi.org/10.1515/afpuc-2016-0004
Vancouver
Gulač P, Vicen M, Hričáková S, Stankovičová T. The incidence of dysrhythmias after administration of the antipsychotic olanzapine. European Pharmaceutical Journal. 2016. doi:10.1515/afpuc-2016-0004
BibTeX
@article{Gula2016,
author = {Gulač, P. and Vicen, M. and Hričáková, S. and Stankovičová, T.},
title = {The incidence of dysrhythmias after administration of the antipsychotic olanzapine},
journal = {European Pharmaceutical Journal},
year = {2016},
doi = {10.1515/afpuc-2016-0004}
}
EUVIMED